AOD-9604
- Generic Name
- AOD-9604
A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Lateral Pharma Pty Ltd
- Target Recruit Count
- 26
- Registration Number
- NCT05298306
- Locations
- ๐ฆ๐บ
PARC Clinical Research, Adelaide, South Australia, Australia
A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine
- First Posted Date
- 2019-11-06
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- Lateral Pharma Pty Ltd
- Target Recruit Count
- 21
- Registration Number
- NCT04153409
- Locations
- ๐ฆ๐บ
Paratus Clinical Research, Blacktown, Sydney, New South Wales, Australia
๐ฆ๐บParatus Clinical Research, Central Coast, Kanwal, New South Wales, Australia
๐ฆ๐บEmeritus Research, Camberwell, Victoria, Australia
Oral LAT8881 in Neuropathic Pain
Phase 2
Completed
- Conditions
- Post Herpetic Neuralgia (PHN)Neuropathic PainDiabetic Peripheral Neuropathy (DPN)
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-03-07
- Last Posted Date
- 2021-06-14
- Lead Sponsor
- Lateral Pharma Pty Ltd
- Target Recruit Count
- 53
- Registration Number
- NCT03865953
- Locations
- ๐ฆ๐บ
Paratus Clinical Research Blacktown, Sydney, New South Wales, Australia
๐ฆ๐บParatus Clinical Research Kanwal, Kanwal, New South Wales, Australia
๐ฆ๐บAusTrials, Brisbane, Queensland, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath